Role of probiotics in patients with Helicobacter pylori infection

Helicobacter

Volumn 12, Issue SUPPL. 2, 2007, Pages 59-63

  Franceschi, Francesco ^a   Cazzato, Alessia ^a   Nista, Enrico C ^a   Scarpellini, Emidio ^a   Roccarina, Davide ^a   Gigante, Giovanni ^a   Gasbarrini, Giovanni ^a   Gasbarrini, Antonio ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Antimicrobial effect; Bifidobacteria; Compliance; Eradication; Lactobacille

Indexed keywords

BUTYRIC ACID; INULIN; PLACEBO; PREBIOTIC AGENT; PROBIOTIC AGENT;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM CULTURE; BIFIDOBACTERIUM; CLINICAL TRIAL; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; DRUG TOLERABILITY; ERADICATION THERAPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INTESTINE FLORA; LACTOBACILLUS; NONHUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; SACCHAROMYCES BOULARDII; STREPTOCOCCUS THERMOPHILUS;

HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PROBIOTICS;

ANIMALIA; HELICOBACTER PYLORI;

EID: 35948989726     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2007.00565.x     Document Type: Article

References (27)

1. Isolauti E. Probiotics in human disease. Am J Clin Nutr 2001 73 : 1142 6S.
2. Cazzato IA, Candelli M, Nista EC, Gasbarrini G, Gasbarrini A. Role of probiotics in Helicobacter pylori infections. Scand J Nutr 2004 26 : 31.
3. Fuller R. Probiotics in human medicine. Gut 1991 32 : 439 42.
4. Metchnikoff E. The Prolongation of Life. London : Heinemann, 1907.
5. Asp NG, Wadstrom T. Probiotics and health-introductory comments and aim of the conference. Scand J Nutr 2004 48 : 14.
6. Asp NG, Mollby R, Norin L, Wadstrom T. Probiotics in gastric and intestinal disorders as functional food and medicine. Scand J Nutr 2004 48 : 14.
7. Michetti P, Dorta G, Wiesel PH, et al. Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans. Digestion 1999 60 : 203 9.
8. Coconnier MH, Lievin V, Hemery E, Servin AL. Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB. Appl Environ Microbiol 1998 64 : 4573 80.
9. Lorca GL, Wadstrom T, Valdez GF, Ljungh A. Lactobacillus acidophilus autolysins inhibit. Helicobacter Pylori Vitro Curr Microbiol 2001 42 : 39 44.
10. Kabir AM, Aiba Y, Takagi A, Kamiya S, Miwa T, Koga Y. Prevention of Helicobacter pylori infection by lactobacilli in a gnotobiotic murine model. Gut 1997 41 : 49 55.
11. Aiba Y, Suzuki N, Kabir AM, Takagi A, Koga Y. Lactic acid-mediated suppression of Helicobacter pylori by the oral administration of Lactobacillus salivarius as a probiotic in a gnotobiotic murine model. Am J Gastroenterol 1998 93 : 2097 101.
12. Mukai T, Asasaka T, Sato E, Mori K, Matsumoto M, Ohori H. Inhibition of binding of Helicobacter pylori to the glycolipid receptors by probiotic Lactobacillus reuteri. FEMS Immunol Med Microbiol 2002 32 : 105 10.
13. Pinchuk IV, Bressollier P, Verneuil B, Fenet B, Sorokulova IB, Megraud F, Urdaci MC. In vitro anti-Helicobacter pylori activity of the probiotic strain Bacillus subtilis 3 is due to secretion of antibiotics. Antimicrob Agents Chemother 2001 45 : 3156 61.
14. Felley CP, Corthesy-Theulaz I, Rivero JL, et al. Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man. Eur J Gastroenterol Hepatol 2001 13 : 25 9.
15. Sakamoto I, Igarashi M, Kimura K, Takagi A, Miwa T, Koga Y. Suppressive effect of Lactobacillus gasseri OLL 2716 (LG21) on Helicobacter pylori infection in humans. J Antimicrob Chemother 2001 47 : 709 10.
16. Canducci F, Armuzzi A, Cremonini F, Cammarota G, Bartolozzi F, Pola P, Gasbarrini G, Gasbarrini A. A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates. Aliment Pharmacol Ther 2000 14 : 1625 9.
17. Sheu BS, Wu JJ, Lo CY, Wu HW, Chen JH, Lin YS, Lin MD. Impact of supplement with Lactobacillus- and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication. Aliment Pharmacol Ther 2002 16 : 1669 75.
18. Marteau P, Rambaud JC. Potential of using lactic acid bacteria for therapy and immunomodulation in man. FEMS Microbiol Rev 1993 12 : 20.
19. Nord CE, Heimdal A, Kager L. Antimicrobial induced alterations of the human oropharyngeal and intestinal microflora. Scand J Infect Dis 1986 49 : 64 72.
20. Adamsson I, Nord CE, Lundquist P, Sjostedt S, Edlund C. Comparative effects of omeprazole, amoxycillin, plus metronidazole versus omeprazole, clarithromycin plus metronidazole on the oral, gastric and intestinal microflora in Helicobacter pylori-infected patients. J Antimicrob Chemother 1999 44 : 40.
21. Lewis SJ, Freedman AR. Review article: the use of biotherapeutic agents in the prevention and treatment of gastrointestinal disease. Aliment Pharmacol Ther 1998 12 : 80722.
22. Armuzzi A, Cremonini F, Ojetti V et al. Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study. Digestion 2001 63 : 1 7.
23. Armuzzi A, Cremonini F, Bartolozzi F, et al. The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther 2001 15 : 163 9.
24. Cremonini F, Di Caro S, Covino M, Armuzzi A, Gabrielli M, Santarelli L, Nista EC, Cammarota G, Gasbarrini G, Gasbarrini A. Effect of different probiotic preparations on anti-Helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study. Am J Gastroenterol 2002 97 : 2744 9.
25. Nista EC, Candelli M, Cremonini F, Cazzato IA, Zocco MA, Franceschi F, Cammarota G, Gasbarrini G, Gasbarrini A. Bacillus clausii therapy to reduce side effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial. Aliment Pharmacol Ther 2004 20 : 1181 8.
26. Duman DG, Bor S, Ozutemiz O, et al. Efficacy and safety of Saccharomyces boulardii in prevention of antibiotic-associated diarrhea due to Helicobacter pylori eradication. Eur J Gastroenterol Hepatol 2005 17 : 1357 61.
27. Tursi A, Brandimarte G, Giorgetti GM, Modeo ME. Effect of Lactobacillus casei supplementation on the effectiveness and tolerability of a new second-line 10-day quadruple therapy after failure of a first attempt to cure Helicobacter pylori infection. Med Sci Monit 2004 10 : CR662 6.